Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,324
Sort by:
Cell Surface Markers 2021: US, Europe, Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 5,350.00
... technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ... report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ...
November 2017
120 pages
UK HIV/AIDS Diagnostics Market 2021: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,300.00
... of the AIDS diagnostics market in the UK. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, ... the definition, epidemiology and etiology of AIDS and other retroviruses. Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies ...
November 2017
251 pages
US HIV/AIDS Diagnostics Market 2021: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,300.00
... of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag/HIV NAT, Western ... the definition, epidemiology and etiology of AIDS and other retroviruses. Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging ...
November 2017
250 pages
Infectious Disease Diagnostics Market 2021: Strategic Assessments of Leading Suppliers
US$ 3,500.00
... technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel ... The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and ...
November 2017
155 pages
